Michael Bots

Author PubWeight™ 13.47^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy.	Blood	2009	1.65
2	Activation of the granzyme pathway in children with severe respiratory syncytial virus infection.	Pediatr Res	2008	1.54
3	Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.	Mol Cell	2011	1.48
4	Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanisms.	J Immunol	2010	1.46
5	Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737.	Cancer Res	2011	1.19
6	NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.	Blood	2012	1.09
7	The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.	Cancer Discov	2012	1.01
8	Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon.	Mol Cancer	2013	0.97
9	Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities.	Mol Cancer Ther	2013	0.94
10	Promises and challenges of anticancer drugs that target the epigenome.	Epigenomics	2011	0.82
11	Does the serpin PI-9 protect tumor cells?	Blood	2006	0.80
12	Antitumor activities and on-target toxicities mediated by a TRAIL receptor agonist following cotreatment with panobinostat.	Int J Cancer	2010	0.78
13	Two novel haemoglobin variants that affect haemoglobin A1c measurement by ion-exchange chromatography.	Clin Chem Lab Med	2015	0.75